Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENTRACTE cardiovascular outcomes study in rheumatoid arthritis
NL-OMON39743Phase 4Active, not recruiting
- Sponsor
- Roche
- Start
- Apr 2012
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in rheumatoid arthritis (RA) comparing Tocilizumab arm with Etanercept arm (2 arms). Started Apr 2012; status: active, not recruiting.
02
Drugs
tocilizumabetanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON39743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39743.